Skip to content

Clinical Trial of OTracker (A device for ovulation tracking)

A study to assess the feasibility of using Oâ??Tracker as a tool to predict the ovulation

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051244
Enrollment
30
Registered
2023-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Trans Vitals Pvt Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Women with BMI less than 18-25, and Blood Pressure in the normal range- (BP-110 to 130 /70 to 90 mmHg), and Pulse rate- 60 to 100 bpm. 2)Women willing to use the Oâ??Tracker device, and comply with the study protocol. 3)Women with regular menstrual cycle-assessment will be based on self-reporting about last three menstrual cycle. Regular menstrual cycle would be defined as follows- length of menstrual cycle- 21 to 35 days Menstrual bleeding duration- 4 to 5 days

Exclusion criteria

Exclusion criteria: Women who are breast-feeding or pregnant. Women using hormonal contraception

Design outcomes

Primary

MeasureTime frame
Practical aspects of using the Oâ??Tracker device and App â?? Users indicating ease of using the device and the App Timepoint: 2 Months

Secondary

MeasureTime frame
Concordance between the ovulation predicted by Oâ??Tracker and ovulation confirmed by urine LH strips.(Lh strips indicates rise in urine luteinizing hormone above the threshold levels, which occurs 24 hours prior to ovulation)Timepoint: 3 Months

Countries

India

Contacts

Public ContactDr Nilangi Sardeshpande

Savitribai Phule Pune University

chavanpriti@gmail.com9657192842

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026